These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 32265836

  • 1. Determinants of the hCG Concentration in the Early Luteal Phase After Final Maturation of Follicles With Bolus Trigger of Recombinant hCG.
    Vuong LN, Pham TD, Ho VNA, Ho TM, Humaidan P, Andersen CY.
    Front Endocrinol (Lausanne); 2020; 11():137. PubMed ID: 32265836
    [Abstract] [Full Text] [Related]

  • 2. The early luteal hormonal profile in IVF patients triggered with hCG.
    Vuong LN, Ho TM, Pham TD, Ho VNA, Andersen CY, Humaidan P.
    Hum Reprod; 2020 Jan 01; 35(1):157-166. PubMed ID: 31967304
    [Abstract] [Full Text] [Related]

  • 3. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY, Elbaek HO, Alsbjerg B, Laursen RJ, Povlsen BB, Thomsen L, Humaidan P.
    Hum Reprod; 2015 Oct 01; 30(10):2387-95. PubMed ID: 26209535
    [Abstract] [Full Text] [Related]

  • 4. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Fatemi HM, Polyzos NP, van Vaerenbergh I, Bourgain C, Blockeel C, Alsbjerg B, Papanikolaou EG, Humaidan P.
    Fertil Steril; 2013 Sep 01; 100(3):742-7. PubMed ID: 23806846
    [Abstract] [Full Text] [Related]

  • 5. HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept.
    Haas J, Kedem A, Machtinger R, Dar S, Hourvitz A, Yerushalmi G, Orvieto R.
    J Ovarian Res; 2014 Apr 03; 7():35. PubMed ID: 24694069
    [Abstract] [Full Text] [Related]

  • 6. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC.
    J Clin Endocrinol Metab; 2003 Sep 03; 88(9):4186-92. PubMed ID: 12970285
    [Abstract] [Full Text] [Related]

  • 7. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
    Humaidan P, Polyzos NP, Alsbjerg B, Erb K, Mikkelsen AL, Elbaek HO, Papanikolaou EG, Andersen CY.
    Hum Reprod; 2013 Sep 03; 28(9):2511-21. PubMed ID: 23753114
    [Abstract] [Full Text] [Related]

  • 8. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
    Humaidan P, Van Vaerenbergh I, Bourgain C, Alsbjerg B, Blockeel C, Schuit F, Van Lommel L, Devroey P, Fatemi H.
    Hum Reprod; 2012 Nov 03; 27(11):3259-72. PubMed ID: 22930004
    [Abstract] [Full Text] [Related]

  • 9. In vitro fertilization outcome based on the detailed early luteal phase trajectory of hormones: a prospective cohort study.
    N Vuong L, D Pham T, N A Ho V, T L Vu A, M Ho T, Yding Andersen C.
    Reprod Biol Endocrinol; 2024 May 20; 22(1):56. PubMed ID: 38769552
    [Abstract] [Full Text] [Related]

  • 10. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA, Kolibianakis EM, Bosdou JK, Lainas GT, Sfontouris IA, Tarlatzis BC, Lainas TG.
    Hum Reprod; 2016 Aug 20; 31(8):1859-65. PubMed ID: 27301360
    [Abstract] [Full Text] [Related]

  • 11. A drop in serum progesterone from oocyte pick-up +3 days to +5 days in fresh blastocyst transfer, using hCG-trigger and standard luteal support, is associated with lower ongoing pregnancy rates.
    Uyanik E, Mumusoglu S, Polat M, Yarali Ozbek I, Esteves SC, Humaidan P, Yarali H.
    Hum Reprod; 2023 Feb 01; 38(2):225-236. PubMed ID: 36478179
    [Abstract] [Full Text] [Related]

  • 12. Response to ovulation trigger is correlated to late follicular phase progesterone levels: A hypothesis explaining reduced reproductive outcomes caused by increased late follicular progesterone rise.
    Friis Wang N, Skouby SO, Humaidan P, Andersen CY.
    Hum Reprod; 2019 May 01; 34(5):942-948. PubMed ID: 30927415
    [Abstract] [Full Text] [Related]

  • 13. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization.
    Fauser BC, de Jong D, Olivennes F, Wramsby H, Tay C, Itskovitz-Eldor J, van Hooren HG.
    J Clin Endocrinol Metab; 2002 Feb 01; 87(2):709-15. PubMed ID: 11836309
    [Abstract] [Full Text] [Related]

  • 14. Hormonal profile in early luteal phase after triggering ovulation with gonadotropin-releasing hormone agonist in high-responder patients.
    Martazanova B, Mishieva N, Vedikhina I, Kirillova A, Korneeva I, Ivanets T, Abubakirov A, Sukhikh GT.
    Front Endocrinol (Lausanne); 2022 Feb 01; 13():834627. PubMed ID: 36046787
    [Abstract] [Full Text] [Related]

  • 15. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK, Schultze-Mosgau A, Cordes T, Diedrich K, Griesinger G.
    Arch Gynecol Obstet; 2013 Oct 01; 288(4):901-4. PubMed ID: 23545834
    [Abstract] [Full Text] [Related]

  • 16. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.
    Devroey P, Fauser BC, Platteau P, Beckers NG, Dhont M, Mannaerts BM.
    J Clin Endocrinol Metab; 2004 May 01; 89(5):2062-70. PubMed ID: 15126522
    [Abstract] [Full Text] [Related]

  • 17. Absence of luteal phase defect and spontaneous pregnancy in IVF patients despite GnRH-agonist trigger and "freeze all policy" without luteal phase support: a report of four cases.
    Gurbuz AS, Deveer R, Ozcimen N, Ozcimen EE, Lawrenz B, Banker M, Garcia-Velasco JA, Fatemi HM.
    Gynecol Endocrinol; 2016 May 01; 32(1):18-20. PubMed ID: 26487486
    [Abstract] [Full Text] [Related]

  • 18. GnRH agonist trigger with intensive luteal phase support vs. human chorionic gonadotropin trigger in high responders: an observational study reporting pregnancy outcomes and incidence of ovarian hyperstimulation syndrome.
    Christopoulos G, Vlismas A, Carby A, Lavery S, Trew G.
    Hum Fertil (Camb); 2016 Sep 01; 19(3):199-206. PubMed ID: 27662416
    [Abstract] [Full Text] [Related]

  • 19. GnRH antagonist and letrozole co-treatment in diminished ovarian reserve patients: a proof-of-concept study.
    Olgan S, Humaidan P.
    Reprod Biol; 2017 Mar 01; 17(1):105-110. PubMed ID: 28173995
    [Abstract] [Full Text] [Related]

  • 20. Multiple-dose versus single-dose gonadotropin-releasing hormone agonist after first in vitro fertilization failure associated with luteal phase deficiency: A randomized controlled trial.
    Qu D, Li Y.
    J Int Med Res; 2020 Jun 01; 48(6):300060520926026. PubMed ID: 32495663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.